mrna-4157,pembrolizumab
moderna,merck
['mrna-4157', 'paradigm', 'pembro', 'merck', 'moderna']
jeff weber presents #neoantigen approach to adjuvant therapy - proud to have been part of this paradigm now open again and accruing - adjuvant mrna-4157 individualized approach with pd1 pembrolizumab #aacr23 
Chief of Research and Immunotherapy  •  ImmunoOncology  •  Phase I  Clinical Trials  •  Melanoma  •  Cutaneous Oncology